| Description |
1 online resource |
| Contents |
Intro; Preface; Acknowledgments; Contents; Contributors; Chapter 1: Definition and Changes in Nomenclature of Hepatic Encephalopathy; Definition; Current Issues with Nomenclature of HE; Classification; Case 1; Case 2; Case 3; Case 4; Case 5; Conclusion; References; Chapter 2: Hepatic Encephalopathy: Pathophysiology-Brain; Clinical Scenario; Causes of Hyperammonemia; Neurotoxicity of Ammonia; Systemic Inflammation and Oxidative Stress; Impact of Recurrent HE; Conclusion; References; Chapter 3: Pathophysiology: Gut Liver Axis Changes; Clinical Scenario: Part 1; Ammonia |
|
Clinical Scenario: Part 2Infection and Inflammation; Clinical Scenario: Part 3; The Gut Microbiome; Modifying the Gut Microbiota May Be Expected to Alter Outcomes in HE; Conclusions; References; Chapter 4: Impact and Diagnosis of Minimal or Grade 1 Hepatic Encephalopathy; Introduction; Portosystemic Encephalopathy Test (PSE); The Continuous Reaction Time Test (CRT); Case 1: HE with No Comorbidity; Winter 2016; Summer 2017; Autumn 2017; Winter 2017; Case 2: Recurrent HE with Co-morbid Medical Diseases; The Impact of Minimal and Grade 1 HE; Diagnosing Minimal and Grade 1 Hepatic Encephalopathy |
|
Isolated Hepatic EncephalopathyHepatic Encephalopathy Associated with Acute-on-Chronic Liver Failure; Pathophysiology of Hepatic Encephalopathy in Acute-on-Chronic Liver Failure; Management of Hepatic Encephalopathy in the Hospitalized Patient; General Approach; Direct Treatment at Precipitating Factors; Specific Treatment; Nonabsorbable Disaccharides; Rifaximin; Neomycin, Metronidazole, and Vancomycin; Zinc; l-Ornithine l-Aspartate; Branched-Chain Amino Acids; Percutaneous Embolization of Large Portosystemic Shunts; Molecular Adsorbent Recirculating System; Liver Transplantation; References |
|
Chapter 7: Prevention of Recurrence of Hepatic EncephalopathyIntroduction; Luminal Agents; Nonabsorbable Disaccharides; Rifaximin; Probiotics; Extraluminal Agents; Glycerol Phenylbutyrate; Branched-Chain Amino Acids (BCAA); Interventions; Embolization of Large Spontaneous Shunt; Balloon-Occluded Retrograde Transvenous Obliteration; Conclusion; References; Chapter 8: Hepatic Encephalopathy Diagnosis Conundrums; Introduction; Instead of HE 1: Seizure in Compensated Cirrhosis and Cerebrovascular Disease; Instead of HE 2: Viral Encephalitis in Decompensated Cirrhosis |
| Summary |
This volume provides a comprehensive, state-of-the-art overview of hepatic encephalopathy. Through a case-based approach, the text reviews new data and studies about the role of microbiota in liver disease and hepatic encephalopathy, explores the burden of hepatic encephalopathy on readmissions, costs, and patient care, and highlights management strategies for patients in differing stages of hepatic encephalopathy. Exploratory new therapies and treatment targets are also discussed in the guide. Written by experts in the field, Diagnosis and Management of Hepatic Encephalopathy: A Case-based Guide is a valuable resource for physicians and researchers who deal with this challenging complication of cirrhosis |
| Bibliography |
Includes bibliographical references and index |
| Notes |
Online resource; title from PDF title page (EBSCO, viewed June 1, 2018) |
| Subject |
Hepatic encephalopathy -- Diagnosis
|
|
Hepatic encephalopathy -- Treatment
|
|
Hepatic Encephalopathy
|
|
Hepatology.
|
|
Gastroenterology.
|
|
HEALTH & FITNESS -- Diseases -- General.
|
|
MEDICAL -- Clinical Medicine.
|
|
MEDICAL -- Diseases.
|
|
MEDICAL -- Evidence-Based Medicine.
|
|
MEDICAL -- Internal Medicine.
|
|
Gastroenterology
|
|
Hepatology
|
|
Medicine
|
| Form |
Electronic book
|
| Author |
Bajaj, Jasmohan S., editor
|
| ISBN |
9783319767987 |
|
3319767984 |
|
